{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:34:17Z","timestamp":1783704857124,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["DGE-1633213"],"award-info":[{"award-number":["DGE-1633213"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103548"],"award-info":[{"award-number":["P20GM103548"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R15 MH104485"],"award-info":[{"award-number":["R15 MH104485"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R15 MH125306"],"award-info":[{"award-number":["R15 MH125306"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH106640"],"award-info":[{"award-number":["R01 MH106640"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010285","name":"University of San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110558","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:17:15Z","timestamp":1749669435000},"page":"110558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-0897","authenticated-orcid":false,"given":"Jazmine D.W.","family":"Yaeger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6216-2899","authenticated-orcid":false,"given":"Megan M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighton J.","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Krupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa D.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-6212","authenticated-orcid":false,"given":"Nathan T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisel","family":"Vali\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sathyanesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-2696","authenticated-orcid":false,"given":"Cliff H.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110558_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7007-6-37","article-title":"Erythropoietin enhances hippocampal long-term potentiation and memory","volume":"6","author":"Adamcio","year":"2008","journal-title":"BMC Biol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuroscience.2003.12.039","article-title":"Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression","volume":"124","author":"Adlard","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110558_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.neuropharm.2025.110558_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22282","article-title":"Learning induces EPO\/EPOr expression in memory relevant brain areas, whereas exogenously applied EPO promotes remote memory consolidation","volume":"78","author":"Almaguer-Melian","year":"2024","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2025.110558_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1601-183X.2012.00801.x","article-title":"Fear extinction and BDNF: translating animal models of PTSD to the clinic","volume":"11","author":"Andero","year":"2012","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2025.110558_bib6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.physbeh.2012.03.005","article-title":"Contrasting hippocampal and amygdalar expression of genes related to neural plasticity during escape from social aggression","volume":"107","author":"Arendt","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110558_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41398-020-00889-0","article-title":"Stress inoculation in mice induces global resilience","volume":"10","author":"Ayash","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib8","volume":"120","author":"Ayash","year":"2023"},{"key":"10.1016\/j.neuropharm.2025.110558_bib108","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41583-021-00513-0","article-title":"Sex differences in anxiety and depression: circuits and mechanisms","volume":"22","author":"Bangasser","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib109","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/mp.2010.66","article-title":"Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology","volume":"15","author":"Bangasser","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1037\/0735-7036.103.1.70","article-title":"Antipredator defensive behaviors in a visible burrow system","volume":"103","author":"Blanchard","year":"1989","journal-title":"J. Comp. Psychol."},{"issue":"Suppl. l","key":"10.1016\/j.neuropharm.2025.110558_bib10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0278-5846(89)90105-X","article-title":"Attack and defense in rodents as ethoexperimental models for the study of emotion","volume":"13","author":"Blanchard","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.neubiorev.2013.06.008","article-title":"The role of behavior in translational models for psychopathology: functionality and dysfunctional behaviors","volume":"37","author":"Blanchard","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110558_bib12","first-page":"5","article-title":"Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, Astrocytes, and microglia","author":"Bond","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib13","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110558_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nlm.2009.01.009","article-title":"Learning strategies during fear conditioning","volume":"91","author":"Carpenter","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2025.110558_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114258","article-title":"Anxiolytic reversal of classically conditioned\/chronic stress-induced gene expression and learning in the Stress Alternatives Model","volume":"440","author":"Carpenter","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110558_bib16","first-page":"16","article-title":"Real-world data on SSRI antidepressant side effects","volume":"6","author":"Cascade","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.neuropharm.2025.110558_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14656566.2017.1285907","article-title":"A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators","volume":"18","author":"Curtiss","year":"2017","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110558_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?","volume":"97","author":"Davies","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110558_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-62703-308-4_8","article-title":"Evaluating effects of EPO in rodent behavioral assays related to depression","volume":"982","author":"Duman","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2288-2-8","article-title":"Do multiple outcome measures require p-value adjustment?","volume":"2","author":"Feise","year":"2002","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.drudis.2016.01.016","article-title":"Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity","volume":"21","author":"Gerhard","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2025.110558_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.biopsych.2008.12.005","article-title":"Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects","volume":"66","author":"Girgenti","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib110","doi-asserted-by":"crossref","first-page":"145893","DOI":"10.1016\/j.brainres.2018.07.026","article-title":"The contribution of orexins to sex differences in the stress response","volume":"1731","author":"Grafe","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110558_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/YCO.0b013e32834de34f","article-title":"Current animal models of anxiety, anxiety disorders, and anxiolytic drugs","volume":"25","author":"Haller","year":"2012","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110558_bib24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.neubiorev.2012.09.001","article-title":"Classical and novel approaches to the preclinical testing of anxiolytics: a critical evaluation","volume":"37","author":"Haller","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110558_bib25","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/npp.2017.259","article-title":"A novel method for chronic social defeat stress in female mice","volume":"43","author":"Harris","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.psych.093008.100321","article-title":"Stress hormone regulation: biological role and translation into therapy","volume":"61","author":"Holsboer","year":"2010","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yhbeh.2003.05.001","article-title":"Conditioned defeat in male and female Syrian hamsters","volume":"44","author":"Huhman","year":"2003","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2025.110558_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2017.07.014","article-title":"Vicarious social defeat stress induces depression-related outcomes in female mice","volume":"83","author":"I\u00f1iguez","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addbeh.2019.01.025","article-title":"The war on antidepressants: what we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read","volume":"97","author":"Jauhar","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110558_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/beheco\/14.3.438","article-title":"A survey of the statistical power of research in behavioral ecology and animal behavior","volume":"14","author":"Jennions","year":"2003","journal-title":"Behav. Ecol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2025.100728","article-title":"Aggression as a contributing factor to social defeat and stress vulnerability","volume":"36","author":"John","year":"2025","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110558_bib32","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1017\/S0140525X1400082X","article-title":"A conceptual framework for the neurobiological study of resilience","volume":"38","author":"Kalisch","year":"2015","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2011.06.059","article-title":"Erythropoietin decreases the excitatory neurotransmitter release probability and enhances synaptic plasticity in mice hippocampal slices","volume":"1410","author":"Kamal","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110558_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fncel.2013.00235","article-title":"Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives","volume":"7","author":"Kaneko","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnsys.2016.00069","article-title":"Putting the \"Biology\" back into \"Neurobiology\": the strength of diversity in animal model systems for neuroscience research","volume":"10","author":"Keifer","year":"2016","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-0327(02)00426-3","article-title":"Epidemiology of women and depression","volume":"74","author":"Kessler","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110558_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41386-023-01717-x","article-title":"The role of neurotrophic factors in novel, rapid psychiatric treatments","volume":"49","author":"Kim","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1160\/TH07-03-0208","article-title":"High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)","volume":"99","author":"Kirkeby","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.neuropharm.2025.110558_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100328","article-title":"Evolution of stress responses refine mechanisms of social rank","volume":"14","author":"Korzan","year":"2021","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110558_bib40","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.conb.2004.08.014","article-title":"Neurotrophin action on a rapid timescale","volume":"14","author":"Kovalchuk","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1017\/S1461145707007560","article-title":"Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response","volume":"10","author":"Kozlovsky","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109949","article-title":"Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress","volume":"252","author":"Krupp","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110558_bib45","article-title":"Immunohistological examination of AKT isoforms in the brain: cell-type specificity that may underlie AKT's role in complex brain disorders and neurological disease","volume":"2","author":"Levenga","year":"2021","journal-title":"Cereb Cortex Commun"},{"key":"10.1016\/j.neuropharm.2025.110558_bib46","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00213-018-4950-4","article-title":"Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression","volume":"235","author":"Levy","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110558_bib47","article-title":"Erythropoietin for cognitive deficits associated with Schizophrenia, Bipolar disorder, and major depression: a systematic review","author":"Li","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2025.110558_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"methods"},{"key":"10.1016\/j.neuropharm.2025.110558_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105032","article-title":"Ecological validity of social defeat stressors in mouse models of vulnerability and resilience","volume":"145","author":"Lyons","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110558_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050677","article-title":"Erythropoietin pathway: a potential target for the treatment of depression","volume":"17","author":"Ma","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib52","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1467-6494.2009.00601.x","article-title":"Predictors and parameters of resilience to loss: toward an individual differences model","volume":"77","author":"Mancini","year":"2009","journal-title":"J. Pers."},{"key":"10.1016\/j.neuropharm.2025.110558_bib53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.npp.1301439","article-title":"Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 Days post administration","volume":"33","author":"Miskowiak","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-009-1641-1","article-title":"Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study","volume":"207","author":"Miskowiak","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110558_bib55","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-011-2511-1","article-title":"Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression","volume":"219","author":"Miskowiak","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110558_bib56","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biopsych.2014.12.013","article-title":"Effects of erythropoietin on hippocampal Volume and memory in mood disorders","volume":"78","author":"Miskowiak","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.expneurol.2006.09.026","article-title":"Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures","volume":"204","author":"Montero","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1034\/j.1600-0706.2003.12010.x","article-title":"Arguments for rejecting the sequential Bonferroni in ecological studies","volume":"100","author":"Moran","year":"2003","journal-title":"Oikos"},{"key":"10.1016\/j.neuropharm.2025.110558_bib59","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1176\/appi.ps.201300059","article-title":"A review of the clinical, economic, and societal Burden of treatment-resistant depression: 1996\u20132013","volume":"65","author":"Mrazek","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.neuropharm.2025.110558_bib60","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/beheco\/arh107","article-title":"A farewell to Bonferroni: the problems of low statistical power and publication bias","volume":"15","author":"Nakagawa","year":"2004","journal-title":"Behav. Ecol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib61","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2019.05.005","article-title":"Fighting females: neural and behavioral consequences of social defeat stress in female mice","volume":"86","author":"Newman","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.728725","article-title":"Erythropoietin and non-erythropoietic derivatives in cognition","volume":"12","author":"Newton","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib64","article-title":"Synaptic regulation of affective behaviors; role of BDNF","author":"Ninan","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4196\/kjpp.2012.16.4.281","article-title":"Comparison of neurite outgrowth induced by erythropoietin (EPO) and carbamylated erythropoietin (CEPO) in hippocampal neural progenitor cells","volume":"16","author":"Oh","year":"2012","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.neuropharm.2025.110558_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072813","article-title":"Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes","volume":"8","author":"Osborn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110558_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nbd.2010.01.015","article-title":"Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke","volume":"38","author":"Osredkar","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuropharm.2025.110558_bib68","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2025.110558_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113576","article-title":"Carbamylated erythropoietin improves recognition memory by modulating microglia in a rat model of pain","volume":"416","author":"Rahmani","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110558_bib70","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.physbeh.2015.03.036","article-title":"Nuance and behavioral cogency: how the visible burrow system inspired the stress-alternatives model and conceptualization of the continuum of anxiety","volume":"146","author":"Robertson","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110558_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/life13091826","article-title":"Synergism of carbamoylated erythropoietin and Insulin-like growth factor-1 in immediate early gene expression","volume":"13","author":"Rothschadl","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.neuropharm.2025.110558_bib73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s13311-018-00680-6","article-title":"Venlafaxine mitigates depressive-like behavior in ovariectomized rats by activating the EPO\/EPOR\/JAK2 signaling pathway and increasing the serum estradiol level","volume":"16","author":"Saad","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2025.110558_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411507","article-title":"Carbamoylated erythropoietin-induced cerebral blood perfusion and vascular gene regulation","volume":"24","author":"Sadanandan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib107","doi-asserted-by":"crossref","first-page":"109754","DOI":"10.1016\/j.pnpbp.2019.109754","article-title":"Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice","volume":"96","author":"Sampath","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib75","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1073\/pnas.0901840106","article-title":"Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons","volume":"106","author":"Sanchez","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110558_bib76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1741-7007-9-27","article-title":"Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice","volume":"9","author":"Sargin","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib77","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41398-018-0168-9","article-title":"Carbamoylated erythropoietin modulates cognitive outcomes of social defeat and differentially regulates gene expression in the dorsal and ventral hippocampus","volume":"8","author":"Sathyanesan","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2016.06.034","article-title":"Cannula implantation into the lateral ventricle does not adversely affect recognition or spatial working memory","volume":"628","author":"Seyer","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110558_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2014.00121","article-title":"Neuropeptide S and BDNF gene expression in the amygdala are influenced by social decision-making under stress","volume":"8","author":"Smith","year":"2014","journal-title":"Frontiers Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.psyneuen.2015.10.016","article-title":"Intensity of anxiety is modified via complex integrative stress circuitries","volume":"63","author":"Smith","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib81","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jnr.23971","article-title":"Evaluating social defeat as a model for psychopathology in adult female rodents","volume":"95","author":"Solomon","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2025.110558_bib82","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.10m06176blu","article-title":"Comorbidity patterns of anxiety and depressive disorders in a large cohort study: The Netherlands Study of Depression and Anxiety (NESDA)","volume":"72","author":"Spinhoven","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2018.09.016","article-title":"Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression","volume":"143","author":"Staton","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110558_bib84","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fnins.2017.00515","article-title":"Learning and CRF-induced indecision during escape and submission in rainbow trout during socially aggressive interactions in the stress-alternatives model","volume":"11","author":"Summers","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib85","article-title":"Female social defeat behavior is modified through orexin 2 receptor activity, balancing pro- and anti-stress circuitry in basolateral amygdala Soc","volume":"47","author":"Summers","year":"2021","journal-title":"Neurosci. Abst."},{"key":"10.1016\/j.neuropharm.2025.110558_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12811-8","article-title":"Establishment of a repeated social defeat stress model in female mice","volume":"7","author":"Takahashi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110558_bib87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2013.01.042","article-title":"The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease","volume":"1502","author":"Thomas Tayra","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110558_bib88","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pnpbp.2018.07.011","article-title":"Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells","volume":"88","author":"Tiwari","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/life11040359","article-title":"A comparative analysis of erythropoietin and carbamoylated erythropoietin proteome profiles","volume":"11","author":"Tiwari","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.neuropharm.2025.110558_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137109","article-title":"STAT5 as a key protein of erythropoietin signalization","volume":"22","author":"T\u00f3thov\u00e1","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ejn.14720","article-title":"Neuroinflammation and depression: a review","volume":"53","author":"Troubat","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib92","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1196\/annals.1364.022","article-title":"Clinical implications of neuroscience research in PTSD","volume":"1071","author":"van der Kolk","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110558_bib93","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1475-6773.2006.00512.x","article-title":"When to combine hypotheses and adjust for multiple tests","volume":"41","author":"Veazie","year":"2006","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.neuropharm.2025.110558_bib94","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.jcbfm.9600370","article-title":"Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives","volume":"27","author":"Villa","year":"2007","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2025.110558_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100059","article-title":"Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity","author":"Yaeger","year":"2020","journal-title":"Medicine in Drug Discovery"},{"key":"10.1016\/j.neuropharm.2025.110558_bib96","first-page":"Y8","article-title":"Female social defeat behavior is modified through orexin 2 receptor activity, balancing pro- and anti-stress circuitry in basolateral amygdala Soc","volume":"48","author":"Yaeger","year":"2022","journal-title":"Neurosci. Abst."},{"key":"10.1016\/j.neuropharm.2025.110558_bib97","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2021.12.019","article-title":"Orexin 1 receptor antagonism in the basolateral amygdala shifts the balance from Pro- to Antistress signaling and behavior","volume":"91","author":"Yaeger","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109168","article-title":"Contextual generalization of social stress learning is modulated by orexin receptors in basolateral amygdala","volume":"215","author":"Yaeger","year":"2022","journal-title":"Neuropharmacology"},{"issue":"31691","key":"10.1016\/j.neuropharm.2025.110558_bib99","article-title":"Learned phenotypes emerge during social stress modifying hippocampal orexin receptor gene expression","volume":"14","author":"Yaeger","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110558_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2010.09.008","article-title":"From the vascular microenvironment to neurogenesis","volume":"84","author":"Yang","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2025.110558_bib102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2007.09.006","article-title":"Response variation following trauma: a translational neuroscience approach to understanding PTSD","volume":"56","author":"Yehuda","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110558_bib103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archpsyc.58.1.55","article-title":"The quality of care for depressive and anxiety disorders in the United States","volume":"58","author":"Young","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102089","article-title":"Glucose metabolic crosstalk and regulation in brain function and diseases","volume":"204","author":"Zhang","year":"2021","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuropharm.2025.110558_bib105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4088\/JCP.08m04978blu","article-title":"Underrecognition of clinically significant side effects in depressed outpatients","volume":"71","author":"Zimmerman","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110558_bib106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1024746316245","article-title":"Chronicity in posttraumatic stress disorder (PTSD) and predictors of course of comorbid PTSD in patients with anxiety disorders","volume":"12","author":"Zlotnick","year":"1999","journal-title":"J. Trauma Stress"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:23:19Z","timestamp":1779614599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":109,"alternative-id":["S0028390825002643"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110558","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110558"}}